Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
-$0.23 today
- Market cap
- $685.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
Volume 0.59M
Average 0.42M
DCTH Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Delcath Systems, Inc.NASDAQ: DCTH
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $102K rose 52.2% year over year, ahead of the +29.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 6.4% from the prior quarter. Over 3 fiscal years it compounded at +38.3% a year.
Context
- Depreciation & amortization amounted to 0.4% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +52.2% holds above the trailing-twelve-month pace of +29.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 349K USD
- Year-over-year change
- +52.4%
- 4-year CAGR
- +24.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 349K | +52.4% |
| FY2024 | 2024-12-31 | 229K | -42.6% |
| FY2023 | 2023-12-31 | 399K | +202.3% |
| FY2022 | 2022-12-31 | 132K | -9.6% |
| FY2021 | 2021-12-31 | 146K | — |
Depreciation & Amortization vs competitors
How DCTH compares with its peers on the latest reported figures
- DCTH's LTM Mar 2026 depreciation & amortization of $330K is the lowest of the 4 companies compared; the peer median is $3.65M.
- Its year-over-year change of +29.9% is the 3rd highest of 4, against a peer median of +35.4%.
- Depreciation & amortization amounts to 0.4% of revenue for DCTH, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $18M | +53.3% | +17.4% | 2.7% | |
| LTM Mar 2026 | $3.65M | +35.4% | +111.4% | 589.8% | |
| LTM Mar 2026 | $589K | -20.5% | +14.8% | 1.3% | |
| LTM Mar 2026 | $330K | +29.9% | +38.3% | 0.4% | |
| Peer median (excluding DCTH) | $3.65M | +35.4% | +17.4% | 2.7% | |
Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.56M | 2.72M | 2.07M | 37.21M | 85.23M |
| Cost of Revenue | 671K | 686K | 635K | 6.19M | 11.8M |
| Gross Profit | 2.88M | 2.03M | 1.43M | 31.02M | 73.43M |
| Gross Margin | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% |
| Research & Development | 13.78M | 18.58M | 17.5M | 13.87M | 29.25M |
| Selling, General & Admin | 13.64M | 17.3M | 22.11M | 29.55M | 43.53M |
| Operating Expenses | 27.42M | 35.89M | 39.61M | 43.43M | 72.77M |
| Depreciation & Amortization | 146K | 132K | 399K | 229K | 349K |
| EBITDA | (24.32M) | (33.69M) | (45.84M) | (26.16M) | 3.86M |
| EBITDA Margin | -684.0% | -1239.1% | -2219.9% | -70.3% | 4.5% |
| Operating Income | (24.53M) | (33.85M) | (38.18M) | (12.41M) | 660K |
| Operating Margin | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% |
| Interest Income | 0 | 0 | 0 | 125K | 2.92M |
| Interest Expense | 1.19M | 2.69M | 1.44M | 0 | 0 |
| Other Income / Expenses | (1.12M) | (2.66M) | (9.5M) | (13.98M) | 2.85M |
| Income Before Tax | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 3.51M |
| Pre-Tax Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 4.1% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 810K |
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Net Margin | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% |
| EPS (Basic) | (3.59) | (4.12) | (2.94) | (0.93) | 0.08 |
| EPS (Diluted) | (3.59) | (4.12) | (2.94) | (0.93) | 0.07 |
| Weighted Avg Shares | 7.15M | 8.86M | 16.23M | 28.51M | 35.82M |
| Weighted Avg Shares (Diluted) | 7.15M | 8.86M | 16.23M | 28.51M | 39.92M |
Delcath Systems, Inc.
NASDAQ:DCTH
Intrinsic Alpha fair value
Locked
Current Price
$19.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.